Bloomberg |
After 190 Tries, Are We Any Closer to a Cure for Alzheimer's?
Bloomberg Eli Lilly has spent almost three decades working on drugs for Alzheimer's disease with not much to show for it yet. This year the company began human tests using a totally new approach. Its latest drug targets an aberrant protein called tau that ... A few tips from experts for interacting with Alzheimer's patients Be prepared for Alzheimer's Alzheimer's Q&A: What are some of the growing statistics on Alzheimer's disease? |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNG4VPJfuORWwDyvxXx5EYYz7VcIyg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779140388227&ei=GQ5xV_DUHc3I3gHSsq3QBA&url=http://www.bloomberg.com/news/articles/2016-06-27/after-190-tries-are-we-any-closer-to-a-cure-for-alzheimer-s
via IFTTT
No comments:
Post a Comment